Source comparison
PT-141 Side Effects in Studies: Adverse Event Comparison
Nausea 40% 13% MC4R activation in area postrema triggers emetic reflex Most common side effect. Predictable, self-limiting within 24 hours in 85% of cases Facial Flushing 30% 2% Melanocortin-mediated peripheral vasodilation Cosmetically noticeable but medicall
This comparison does not assign a generated winner or score.
- Nausea
- 40%
- 13%
- MC4R activation in area postrema triggers emetic reflex
- Most common side effect. Predictable, self-limiting within 24 hours in 85% of cases
- Facial Flushing
- 30%
- 2%
- Melanocortin-mediated peripheral vasodilation
- Cosmetically noticeable but medically benign. Resolves within 60–90 minutes
- Headache
- 20%
- 11%
- Likely vasodilation-related, exacerbated by transient BP changes
- Mild to moderate intensity. Responsive to standard NSAIDs
- Transient Hypertension (≥20/10 mmHg)
- 2.8%
- <1%
- MC4R-driven sympathetic activation increases vascular tone
- Requires cardiovascular screening before prescribing. Contraindicated in uncontrolled HTN
- Injection Site Reactions
- 8%
- 3%
- Local inflammatory response to subcutaneous injection
- Minor. Rotating sites reduces recurrence
- Discontinuation Due to AEs
- 4.1%
- 1.2%
- Primarily driven by persistent nausea or flushing intolerance
- Low overall discontinuation rate suggests most effects are tolerable